Free consult first, no pressure. You pay only if our medical team prescribes it for you.
Start online or in person. It only takes a minute, and the consultation can be done from home.
They review your health history and your goals, and talk through whether a peptide is a good fit for you.
If a peptide is appropriate, your provider writes the prescription. If it is not the right choice for you, they will tell you that too.
We prepare your prescription so it is ready for your visit. Your card is charged when the prescription is processed.
IDEAL FOR
PT-141 is prescribed after a private consultation where a provider reviews your history and goals.
Adults concerned about low desire or arousal
People who want an option that works centrally, not just on circulation
Anyone who prefers a discreet, provider-guided conversation
Book a free, confidential consultation with our medical team to see if it is appropriate.
PT-141, also called bremelanotide, works through the central nervous system rather than on blood flow alone. It is studied for sexual desire and arousal in both men and women, and a related form is approved for a specific low-desire condition in premenopausal women. Any use here is individualized and prescription-only.
Low sexual desire and arousal in men and women
Support for premenopausal women with hypoactive sexual desire
A different mechanism from blood-flow-focused options
PT-141 is not FDA-approved and is not offered at Cienega Medical. This page is for general education only and is not medical advice.
PT-141 (bremelanotide) is a synthetic peptide that belongs to the melanocortin class and acts on melanocortin receptors in the central nervous system. One formulation of bremelanotide is marketed under the brand name Vyleesi, which received U.S. FDA approval in 2019 as a prescription product. Outside of that specific FDA-approved branded product, raw or compounded PT-141 peptide is generally categorized as a research peptide and is not an FDA-approved drug in those forms. This page is provided for general educational reference only.
Click on a question to see more
PT-141, also called bremelanotide, is a synthetic peptide in the melanocortin family that interacts with melanocortin receptors. It has been the subject of scientific and clinical research, and one branded formulation has been reviewed by regulators.
A specific branded formulation of bremelanotide (Vyleesi) received FDA approval in 2019 as a prescription product. PT-141 sold as a raw or compounded research peptide is not an FDA-approved drug and is generally classified as a research compound.
No. PT-141 is not offered at Cienega Medical. This page exists solely for general educational reference.
Cared for by our 12-person Los Angeles medical team. Meet your provider →
In-person, physician-supervised care at all three Cienega Medical clinics.